Prodrug Activation Kinetics

Reaction Rates

Hydrolysis rate k₁ (prodrug → drug) 0.90 /h

Elimination rate k₂ (drug cleared) 0.35 /h

Dose (molecules simulated) 220

Simulation speed 2.0 h/s

Molecule Populations

Prodrug (inactive) Active drug Eliminated

Prodrug remaining

100.0%

Active drug

0.0%

Eliminated

0.0%

Time elapsed

0.0 h

How it works

A prodrug is an inactive or low-activity molecule (often an ester, carbamate or phosphate mask on the real drug) that is designed for better absorption, solubility or targeting. Once inside the body it is bioactivated — usually by esterases, phosphatases or CYP450 enzymes cleaving off the masking group — into the pharmacologically active parent drug, which is then eliminated by the usual clearance pathways.

This is a two-step sequential first-order process, the same math used to model real prodrug pharmacokinetics (and, formally, a radioactive decay chain):

dP/dt = -k1·P            (prodrug hydrolysis)
dA/dt =  k1·P - k2·A      (active drug appears, then clears)

P(t) = P0 e^(-k1 t)
A(t) = P0 k1/(k2-k1) · (e^(-k1 t) - e^(-k2 t))

Rather than solving the ODE directly, each of the N molecules in the 3D view is simulated individually as a stochastic event: on every timestep dt, a prodrug molecule converts with probability 1 − e^(−k1·dt), and an active-drug molecule is cleared with probability 1 − e^(−k2·dt) — the exact discrete-time form of a Poisson process with rate k. Summed over hundreds of molecules this individually-random behaviour reproduces the smooth exponential curves above almost exactly, which is also why real drug concentration data is never perfectly smooth at the molecular scale.

k1 (hydrolysis) — how fast the masking group is cleaved. Higher k1 means the prodrug converts almost immediately (little benefit over dosing the active drug directly); very low k1 means most of the dose is excreted unconverted.
k2 (elimination) — how fast the liberated active drug is cleared. The ratio k1/k2 sets whether the process is "activation-limited" or "elimination-limited", which is exactly the flip-flop kinetics problem real pharmacokineticists have to watch for.
Real examples of this exact mechanism: enalapril → enalaprilat (ester hydrolysis, ACE inhibitor), valacyclovir → acyclovir (esterase), and codeine → morphine (CYP2D6 O-demethylation).

Prodrug Active drug Eliminated

⚠ Couldn't load the 3D engineThree.js failed to load from the CDN. Check your connection and reload.